Open access
Open access
Powered by Google Translator Translator

Pfizer and BioNTech to submit Covid-19 vaccine data to FDA as full results show 95% efficacy

19 Nov, 2020 | 09:36h | UTC

Pfizer and BioNTech to submit Covid-19 vaccine data to FDA as full results show 95% efficacy – STAT

News release: Pfizer and Biontech conclude phase 3 study of Covid-19 vaccine candidate, meeting all primary efficacy endpoints

Commentaries: ‘Incredible milestone for science.’ Pfizer and BioNTech update their promising COVID-19 vaccine result – Science AND Pfizer: COVID-19 shot 95% effective, seeking clearance soon – Associated Press AND Expert reaction to announcement by Pfizer that they have concluded the Phase III study of their COVID-19 vaccine candidate after demonstrating 95% efficacy – Science Media Centre AND Covid vaccine: Pfizer says ‘94% effective in over-65s’ – BBC

 


Stay Updated in Your Specialty

 

No spam, just news.